Phathom Pharmaceuticals Inc PHAT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:46 AM EDT
10.20quote price arrow up+0.11 (+1.09%)
Volume
166,541
52 week range
6.07 - 17.02
Loading...
  • Open10.16
  • Day High10.56
  • Day Low10.05
  • Prev Close10.09
  • 52 Week High17.02
  • 52 Week High Date08/11/23
  • 52 Week Low6.07
  • 52 Week Low Date02/13/24

Key Stats

  • Market Cap596.946M
  • Shares Out58.52M
  • 10 Day Average Volume0.63M
  • Dividend-
  • Dividend Yield-
  • Beta0.68
  • YTD % Change10.95

KEY STATS

  • Open10.16
  • Day High10.56
  • Day Low10.05
  • Prev Close10.09
  • 52 Week High17.02
  • 52 Week High Date08/11/23
  • 52 Week Low6.07
  • 52 Week Low Date02/13/24
  • Market Cap596.946M
  • Shares Out58.52M
  • 10 Day Average Volume0.63M
  • Dividend-
  • Dividend Yield-
  • Beta0.68
  • YTD % Change10.95

RATIOS/PROFITABILITY

  • EPS (TTM)-3.89
  • P/E (TTM)-2.62
  • Fwd P/E (NTM)-1.99
  • EBITDA (TTM)-166.722M
  • ROE (TTM)-3,489.00%
  • Revenue (TTM)681,999.981
  • Gross Margin (TTM)75.51%
  • Net Margin (TTM)-29,558.94%
  • Debt To Equity (MRQ)-611.29%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Phathom Pharmaceuticals Inc

Profile

MORE
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s pipeline product candidate, VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan...
Michael Cola
Independent Chairman of the Board
Terrie Curran
President, Chief Executive Officer, Director
Molly Henderson CPA
Chief Financial Officer and Business Officer
Address
100 Campus Drive, Suite 102
Florham Park, NJ
07932
United States

Top Peers

SYMBOLLASTCHG%CHG
IGMS
IGM Biosciences Inc
10.27+0.15+1.43%
AVTE
Aerovate Therapeutics Inc
20.41-1.15-5.33%
CABA
Cabaletta Bio Inc
11.74-0.48-3.93%
OLMA
Olema Pharmaceuticals Inc
9.92+0.08+0.81%
LYEL
Lyell Immunopharma Inc
2.62-0.06-2.24%